Carta científicaReactivación de tuberculosis pulmonar durante el tratamiento con triple terapia de la hepatitis CReactivation of pulmonary tuberculosis during treatment with triple therapy for hepatitis C
Bibliografía (8)
- et al.
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis
J Hepatol
(2015) - et al.
Tuberculous sepsis during antiviral HCV triple therapy
J Hepatol
(2013) - et al.
Pulmonary tuberculoma in a patient with chronic hepatitis C: A clinical pitfall in the treatment strategy
Intern Med
(2014) - et al.
Tuberculosis screening before anti-hepatitis C virus therapy in prisons
Emerg Infect Dis
(2012)
There are more references available in the full text version of this article.
Cited by (2)
Reactivation of peritoneal and pleural tuberculosis during hepatitis C treatment with direct-acting antivirals
2019, Gastroenterologia y HepatologiaMiliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
2017, World Journal of Hepatology
Copyright © 2015 Elsevier España, S.L.U. y AEEH y AEG. All rights reserved.